Program - Society of Toxicology
Program - Society of Toxicology
Program - Society of Toxicology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Society</strong> <strong>of</strong> <strong>Toxicology</strong> 2011<br />
<strong>Program</strong> Description (Continued)<br />
Abstract #<br />
#770 Poster Board Number.....................................833<br />
CADMIUM CAUSES OVER-<br />
ACCUMULATION OF P53 THROUGH THE<br />
SUPPRESSION OF GENE EXPRESSION<br />
OF UBE2D FAMILY IN RAT PROXIMAL<br />
TUBULE CELLS. M. Tokumoto 1,2 , Y. Fujiwara 2 ,<br />
T. Hasegawa 3 , Y. Seko 3 , H. Nagase 1 and M. Satoh 2 .<br />
1<br />
Laboratory <strong>of</strong> Hygienic Chemistry and Molecular<br />
<strong>Toxicology</strong>, Gifu Pharmaceutical University, Gifu,<br />
Japan, 2 Laboratory <strong>of</strong> Pharmaceutical Health Science,<br />
School <strong>of</strong> Pharmacy, Aichi Gakuin University,<br />
Nagoya, Japan and 3 Department <strong>of</strong> Environmental<br />
Biochemistry, Yamanashi Institute <strong>of</strong> Environmental<br />
Sciences, Fujiyoshida, Japan.<br />
#771 Poster Board Number.....................................834<br />
CHANGES TO CONNEXIN EXPRESSION<br />
IN METALLOTHIONEIN-3 POSITIVE AND<br />
NEGATIVE HUMAN PROXIMAL TUBULE<br />
CELLS AFTER CADMIUM TREATMENT. <br />
L. C. Burgess, T. E. Bhobho, J. R. Murray and<br />
M. C. McCoy. Natural Sciences, Dickinson State<br />
University, Dickinson, ND.<br />
#772 Poster Board Number.....................................835<br />
STATISTICAL ANALYSIS OF<br />
LONGITUDINAL GENE EXPRESSION<br />
PROFILES IN HUMAN PROXIMAL TUBULE<br />
CELLS EXPOSED TO CADMIUM. S. H.<br />
Garrett, K. Clarke, D. A. Sens, S. Somji, M. Sens and<br />
K. Zhang. Pathology, University <strong>of</strong> North Dakota,<br />
Grand Forks, ND.<br />
#773 Poster Board Number.....................................836<br />
ASSOCIATIONS OF MULTIPLE METALS<br />
WITH KIDNEY OUTCOMES IN LEAD<br />
WORKERS. R. L. Shelley 1 , N. Kim 2 , P. J. Parsons 3 ,<br />
J. Agnew 1 , A. J. Steuerwald 3 , B. G. Jaar 1 , B. Lee 2 , B.<br />
S. Schwartz 1 , G. Matanoski 1 , A. C. Todd 4 , D. Simon 5<br />
and V. Weaver 1 . 1 Johns Hopkins Bloomberg School<br />
<strong>of</strong> Public Health, Baltimore, MD, 2 SoonChunHyang<br />
University, Asan, Republic <strong>of</strong> Korea, 3 New York<br />
State Department <strong>of</strong> Health, Albany, NY, 4 Mount<br />
Sinai School <strong>of</strong> Medicine, New York, NY and<br />
5<br />
Biostatistical Consulting, Cincinnati, OH.<br />
#774 Poster Board Number.....................................837<br />
GENDER DIFFERENCES IN THE<br />
MOLECULAR MECHANISMS OF BROMATE<br />
INDUCED NEPHROTOXICITY IN F344<br />
RATS. N. Kolisetty 1 , D. A. Delker 2 , C. Nelson 2 ,<br />
S. Muralidhara 1 , R. J. Bull 3 , O. Quinones 4 , G.<br />
Zhongxian 5 , S. Snyder 4 , J. Cotruvo 6 , J. W. Fisher 7 , C.<br />
Ong 8 and B. S. Cummings 1 . 1 University <strong>of</strong> Georgia,<br />
Athens, GA, 2 University <strong>of</strong> Utah, Salt Lake City,<br />
UT, 3 Mo Bull Consulting, Richland, WA, 4 Water<br />
Quality Research and Development, Henderson,<br />
NV, 5 Center for Advanced Water Technology,<br />
Singapore, Singapore, 6 Joseph Cotruvo & Assoc.,<br />
LLC, Washington, D.C., 7 University <strong>of</strong> Georgia,<br />
Athens, GA and 8 National University <strong>of</strong> Singapore,<br />
Singapore, Singapore.<br />
Abstract #<br />
Monday Afternoon, March 7<br />
1:00 PM to 4:30 PM<br />
Exhibit Hall<br />
Novel Approaches to Preclinical Safety Assessment:<br />
Bridging the Gap between Discovery and the Clinic<br />
through Translational <strong>Toxicology</strong><br />
Poster Session: Pharmaceutical Safety Assessment:<br />
Therapeutic Agents<br />
Chairperson(s): Anne Gilson, Forest Research Institute, Jersey City, NJ.<br />
Displayed: 1:00 PM–4:30 PM<br />
Author Attended: 1:00 PM–2:45 PM<br />
#775 Poster Board Number.....................................901<br />
NKTR-181, A NOVEL POLYMER<br />
CONJUGATED OPIOID AGONIST,<br />
DEMONSTRATES REDUCED TOXICITY<br />
AND CNS SIDE EFFECTS RELATIVE TO<br />
OXYCODONE. E. Tonkin, S. Wong, A. Odinecs<br />
and T. D. Sweeney. Nektar Therapeutics, San Carlos,<br />
CA.<br />
#776 Poster Board Number.....................................902<br />
RELATIVE TOXICITY ANALYSIS OF<br />
DL11F, A HER3, AND EGFR DUAL ACTION<br />
ANTIBODY, AND CETUXIMAB IN<br />
CYNOMOLGUS MONKEYS. R. Prell 1 , D.<br />
Danilenko 1 , C. Wang 1 , A. Kamath 1 , G. Schaefer 1 ,<br />
P. Allen 2 , J. Roberts 2 and W. Halpern 1 . 1 Genentech,<br />
South San Francisco, CA and 2 Valley Biosystems,<br />
West Sacramento, CA.<br />
#777 Poster Board Number.....................................903<br />
NONCLINICAL CARCINOGENICITY<br />
ASSESSMENT OF PRASUGREL. L. A.<br />
Buckley 2 , A. Sanbuissho 1 , J. J. Starling 2 , M. Knadler 2<br />
and J. A. Jakubowski 2 . 1 Daiichi Sankyo Co., Ltd.,<br />
Tokyo, Japan and 2 Eli Lilly & Co., Indianapolis, IN.<br />
#778 Poster Board Number.....................................904<br />
OFF-TARGET PLATELET ACTIVATION<br />
IN MACAQUES BY A THERAPEUTIC<br />
MONOCLONAL ANTIBODY. M. J.<br />
Santostefano 1 , N. E. Everds 2 , H. M. Vargas 3 , M. Fort 4 ,<br />
P. Narayanan 4 , D. Tran 2 , W. Pan 5 , J. Kirchner 6 , C.<br />
Vissinga 6 and G. S. Elliott 7 . 1 CBSS - <strong>Toxicology</strong>,<br />
Amgen, Seattle, WA, 2 CBSS - Pathology, Amgen,<br />
Seattle, WA, 3 CBSS - Investigative <strong>Toxicology</strong>,<br />
Amgen, Thousand Oaks, CA, 4 CBSS - Investigative<br />
<strong>Toxicology</strong>, Amgen, Seattle, WA, 5 Pharmacokinetics<br />
and Drug Metabolism, Amgen, Seattle, WA,<br />
6<br />
Inflammation Research, Amgen, Seattle, WA and<br />
7<br />
Clinical Pathology, Charles River Laboratories,<br />
Reno, NV.<br />
#779 Poster Board Number.....................................905<br />
CINACALCET HCL: 6-MONTH ORAL<br />
TOXICITY STUDY IN JUVENILE BEAGLE<br />
DOGS. K. Black 1 , C. Dean 1 , N. Everds 1 , E. Lesage 2<br />
and M. Loomis 1 . 1 Amgen Inc., Thousand Oaks, CA<br />
and 2 Charles River Laboratories Preclinical Services,<br />
Senneville, QC, Canada.<br />
MONday<br />
Poster Sessions<br />
Regional Interest Session<br />
Roundtable Sessions<br />
Symposium Sessions<br />
Thematic Sessions<br />
Workshop Sessions<br />
181